Correction to: Cost Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, and Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: A Systematic Review
Crossref DOI link: https://doi.org/10.1007/s40273-019-00833-1
Published Online: 2019-09-04
Published Print: 2019-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hong, Dongzhe
Si, Lei
Jiang, Minghuan
Shao, Hui
Ming, Wai-kit
Zhao, Yingnan
Li, Yan
Shi, Lizheng
Text and Data Mining valid from 2019-09-04
Version of Record valid from 2019-09-04
Article History
First Online: 4 September 2019
Free to read: This content has been made available to all.